Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

The Men's Training Cup Keep Training masturbation aid may help delay ejaculation and improve erectile function.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.